Gland Pharma: carbon disclosure.
What Gland Pharma published, drawn only from its own SEBI BRSR and XBRL filings.
Gland Pharma disclosed Scope 1 emissions of 29,428 tCO2e and Scope 2 emissions of 57,801 tCO2e in its FY2025-26 BRSR filing. It published a Scope 3 figure of 13,920 tCO2e, reported as a single total without a category breakdown. Its BRSR Core attributes carry reasonable assurance, provided by DNV Business Assurance India Private Lim.
The disclosure record.
Every row is taken from the company's own filings. Where a row says not published, it means no figure was found in the filings reviewed, which is not the same as the company having no such figure.
| Disclosure | As filed |
|---|---|
| Scope 1 | 29,428 tCO2e |
| Scope 2 | 57,801 tCO2e |
| Scope 3 | 13,920 tCO2e |
| Scope 3 by category | Not published in the filings reviewed |
| BRSR Core assurance | Reasonable assurance confirmed (DNV Business Assurance India Private Lim) |
| SBTi | Not published in the filings reviewed |
| CDP | Not published in the filings reviewed |
| Net-zero target year | 2050 |
| Renewable electricity | 4.9% |
| Methodology documented | Yes |
How Pharma & Healthcare discloses.
Across all 1,246 Indian BRSR filers, 65.2% publish a Scope 3 figure and 43.4% carry confirmed reasonable assurance. Full method and figures in The State of Carbon Disclosure in India.
Where the pressure lands next.
Based on the filings reviewed, the items not yet published are Scope 3 split by GHG Protocol category. Reasonable assurance on BRSR Core reaches the top 1,000 listed entities in FY 2026-27, and an assurer works back from each reported figure to the document behind it.
Is this your company? Run the full diagnostic, free.
Run a Carbon X-Ray →Common questions.
Does Gland Pharma disclose Scope 3 emissions?
Yes. Gland Pharma published a Scope 3 figure of 13,920 tCO2e, as a single total without a category breakdown.
Are Gland Pharma's carbon numbers assured?
Yes. Its BRSR Core attributes carry reasonable assurance, provided by DNV Business Assurance India Private Lim. Reasonable assurance is the higher of the two assurance levels and requires substantive testing back to source documents.
Where does this data come from?
SEBI BRSR and XBRL filings, BRSR Core assurance statements, the SBTi target dashboard and the CDP registry. Only figures the company itself published are attributed to it. Data as at 2026-09-25. Corrections to growth@climes.io.